Related Experiment Video
Updated: Jan 6, 2026

09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
Combined Immunotherapy in Metastatic Melanoma with Unknown Primary
Yasir Khan1, Nishanth Thalambedu1
1Internal Medicine, Abington Hospital - Jefferson Health, Abington, USA.
Cureus
|October 11, 2019
Abstract:
Melanoma is skin cancer arising from melanocytes. It may metastasize to unusual areas of the body. Metastatic melanoma with unknown primary (MUP) is relatively uncommon. We present a case of MUP in a 55-year-old male, who underwent adjuvant treatment with combined immunotherapy and showed a good response. We report this case to alert fellow physicians that immunotherapy can be used in MUP with excellent outcomes.

